212 related articles for article (PubMed ID: 26732683)
21. The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women.
Dow A; Kayira D; Hudgens MG; Van Rie A; King CC; Ellington S; Chome N; Kourtis A; Turner AN; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
Infect Dis Obstet Gynecol; 2013; 2013():340702. PubMed ID: 24363547
[TBL] [Abstract][Full Text] [Related]
22. Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria.
Na Bangchang K; Davis TM; Looareesuwan S; White NJ; Bunnag D; Karbwang J
Trans R Soc Trop Med Hyg; 1994; 88(3):321-3. PubMed ID: 7974678
[TBL] [Abstract][Full Text] [Related]
23. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Boudreau EF; Pang LW; Chaikummao S; Witayarut C
Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
[TBL] [Abstract][Full Text] [Related]
24. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Botero D; Restrepo M; Montoya A
Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
[TBL] [Abstract][Full Text] [Related]
25. Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
Briand V; Escolano S; Journot V; Massougbodji A; Cot M; Tubert-Bitter P
Am J Trop Med Hyg; 2015 Aug; 93(2):300-4. PubMed ID: 26055735
[TBL] [Abstract][Full Text] [Related]
26. Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin.
Denoeud-Ndam L; Clément MC; Briand V; Akakpo J; Agossou VK; Atadokpédé F; Dossou-Gbété L; Komongui DG; Afangnihoun A; Girard PM; Zannou DM; Cot M
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):64-72. PubMed ID: 22706291
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
[TBL] [Abstract][Full Text] [Related]
28. Is cotrimoxazole prophylaxis effective to prevent malaria in HIV-infected pregnant women?
Denoeud-Ndam L; Briand V; Zannou DM; Girard PM; Cot M
Clin Infect Dis; 2014 Aug; 59(4):603-4. PubMed ID: 24771502
[No Abstract] [Full Text] [Related]
29. Efficacy and safety of malarial prophylaxis with mefloquine during pregnancy in Kisangani, Democratic Republic of Congo: A randomized clinical trial.
Labama Otuli N; Marini Djang'eing'a R; Losimba Likwela J; Bosenge Nguma JD; Maindo Alongo MA; Ahuka Ona Longombe A; Mbutu Mango B; M N Bono D; L Mokili J; Manga Okenge JP
Br J Clin Pharmacol; 2021 Aug; 87(8):3115-3126. PubMed ID: 33398890
[TBL] [Abstract][Full Text] [Related]
30. Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Bunnag D; Malikul S; Chittamas S; Chindanond D; Harinasuta T; Fernex M; Mittelholzer ML; Kristiansen S; Sturchler D
Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):777-82. PubMed ID: 1298089
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
[TBL] [Abstract][Full Text] [Related]
32. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Poirot E; Vittinghoff E; Ishengoma D; Alifrangis M; Carneiro I; Hashim R; Baraka V; Mosha J; Gesase S; Chandramohan D; Gosling R
PLoS One; 2015; 10(11):e0142414. PubMed ID: 26599634
[TBL] [Abstract][Full Text] [Related]
33. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes.
Serra-Casas E; Menéndez C; Bardají A; Quintó L; Dobaño C; Sigauque B; Jiménez A; Mandomando I; Chauhan VS; Chitnis CE; Alonso PL; Mayor A
J Infect Dis; 2010 Jan; 201(1):123-31. PubMed ID: 19954383
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malaria.
Karbwang J; Back DJ; Bunnag D; Breckenridge AM
Bull World Health Organ; 1990; 68(5):633-8. PubMed ID: 2289299
[TBL] [Abstract][Full Text] [Related]
35. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
Gill CJ; Macleod WB; Mwanakasale V; Chalwe V; Mwananyanda L; Champo D; Mukwamataba D; Chilengi R; Thea DM; Hamer DH
J Infect Dis; 2007 Dec; 196(11):1577-84. PubMed ID: 18008240
[TBL] [Abstract][Full Text] [Related]
36. Mefloquine safety and tolerability in pregnancy: a systematic literature review.
González R; Hellgren U; Greenwood B; Menéndez C
Malar J; 2014 Feb; 13():75. PubMed ID: 24581338
[TBL] [Abstract][Full Text] [Related]
37. A phase I clinical trial of mefloquine in Brazilian male subjects.
de Souza JM
Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
[TBL] [Abstract][Full Text] [Related]
38. Preventing malaria in HIV-infected pregnant women.
Bulterys PL; Kaplan JE; Gutman J
Clin Infect Dis; 2014 Mar; 58(5):660-2. PubMed ID: 24336822
[No Abstract] [Full Text] [Related]
39. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
Simpson JA; Price R; ter Kuile F; Teja-Isavatharm P; Nosten F; Chongsuphajaisiddhi T; Looareesuwan S; Aarons L; White NJ
Clin Pharmacol Ther; 1999 Nov; 66(5):472-84. PubMed ID: 10579474
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic sulfamethoxazole and trimethoprim in ventriculoperitoneal shunt surgery. A double-blind, randomized, placebo-controlled trial.
Wang EE; Prober CG; Hendrick BE; Hoffman HJ; Humphreys RP
JAMA; 1984 Mar; 251(9):1174-7. PubMed ID: 6363740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
